Description
A liquid biopsy is a largely non-invasive, sampling and analysis of liquid state biological tissue for diagnostic and monitoring diseases such as cancer. Liquid biopsy is the direct clinical application of two advances in medical science namely human genome sequencing and rising sensitivity of detecting techniques and assays.
The global Liquid Biopsy market is currently valued at $ 3950 million and will reach $ 17,372.28 million growing at a CAGR of 28%. The growth factors responsible for this explosive growth are liquid biopsy is a comparatively painless and non-invasive technique which provides early real time high precision detection of diseases which could be used for monitoring and designing effective treatment strategies based on the real time molecular assessment for the progression of the disease. Other factors driving the liquid biopsy market are lifestyle changes and environmental factors such as rising investment in research and development and collaborations between companies and public organizations, rise in population particularly geriatric population, rising expenditure on health etc. The technique also has other advantages over traditional tissue biopsy such as potential applications to cardiovascular diseases, autoimmune diseases etc.
The restraints include the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. Also not all cancers patients benefit from early detection as some cancers such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Key Players for Global Liquid Biopsy market:
Guardant Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics, Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics and others.
Study objectives of IV solutions market
• To provide insights about factors influencing and affecting the market growth.
• To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets.
• To provide historical and forecast revenue of the market segments based on types, applications, samples, end users, and its sub-segments.
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Target Audience
• Global Liquid Biopsy manufacturers
• Global Liquid Biopsy suppliers
• Research and development Laboratories
• Market Research and Consulting Service Providers
Key findings
• Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48 % of the revenue share of the liquid biopsy market.
• On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.
• The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period
Segments
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.
Regional Analysis of Global Liquid Biopsy market
Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future. North America accounted for the largest market share of 37.95% in 2016 accounting for a market value of 1,499.10 million in 2016. Asia pacific is the fastest growing market which is growing at a CAGR of 28.8%.
1 Report Prologue 14
2 Introduction 15
2.1 Scope of Study 15
2.2 Research Objective 15
2.3 Assumptions & Limitations 15
2.3.1 Assumptions 15
2.3.2 Limitations 16
2.4 Market Structure 16
3 Research Methodology 17
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 18
4 Market Dynamics 19
4.1 Introduction 19
4.2 Drivers 19
4.2.1 Comparatively painless and non-invasive technique 19
4.2.2 Early real time high precision detection of diseases 19
4.2.3 Useful for designing effective treatment strategies based on the real time molecular assessment for the progression of the disease 19
4.2.4 Rise in cases of cancer and other diseases 20
4.2.5 Lifestyle changes and environmental factors 20
4.2.6 Other advantages over other techniques 20
4.2.7 The recent technological advancements has increased the appeal of liquid biopsy 20
4.2.8 Transferability of liquid biopsy 21
4.2.9 Rising investment in research and development and collaborations between companies and public organizations 21
4.2.10 Greater focus on venture capital 21
4.2.11 Demographical factors 21
4.3 Restraints 22
4.3.1 Prohibitive costs associated with liquid biopsy 22
4.3.2 Lower sensitivity for certain biomarkers 22
4.3.3 Not all cancers patients benefit from early detection 22
4.3.4 Liquid biopsy is not all non-invasive 22
4.3.5 Differential awareness and availability between developing and developed world 22
4.3.6 Issues in venture capital, startups and collaborations 23
4.4 Opportunities 23
4.4.1 Growing collaboration between companies has become the entrance gateway for new firms 23
4.4.2 Funding from public organizations is a good strategy to reduce development costs 23
4.4.3 Rise in research and development investment 23
4.4.4 Developing economies provide an unserved market for liquid biopsy 23
4.4.5 Growing trend of start-ups and venture investment in the field of liquid biopsy 24
4.5 Challenges 24
4.5.1 Information and interest gap between the investors and the developers 24
4.5.2 Lack of trained professionals in developing regions 24
4.5.3 Lack of standardization and transparency 24
5 Market Factor Analysis 26
5.1 Porter’s Five Force Analysis 26
5.1.1 Bargaining Power of Buyer 27
5.1.2 Bargaining Power of Supplier 28
5.1.3 Threat from substitute 28
5.1.4 Threat from a New Entrant 28
5.1.5 Intensity of Competitive Rivalry 28
5.2 Value Chain Analysis 29
5.2.1 Device Manufacturers 30
5.2.2 Software developers 30
5.2.3 Reagent and accessory suppliers 30
5.2.4 Healthcare providers 30
5.2.5 Patients 30
6 Liquid Biopsy Market, By Biomarker Types 31
6.1 Introduction 32
6.2 Circulating Tumor Cells (CTCs) 33
6.3 Circulating Tumour DNA (CtDNA) 34
6.4 Extracellular Vesicles (EVs) 35
6.5 Other biomarker (circulating RNA and proteins) 36
7 Global Liquid Biopsy Market by Application 38
7.1 Introduction 38
7.2 Cancer therapeutic application 39
7.3 Reproductive health 40
7.4 Other therapeutic application market 41
8 Global Liquid Biopsy Market by Sample 43
8.1 Introduction 43
8.2 Blood Sample market, by region, 2015 & 2022 ($ million) 44
8.3 Urine sample market, by region, 2015 & 2022 ($ million) 45
8.4 Other sample market, by region, 2015 & 2022 ($ million) 46
9 Global Liquid Biopsy Market by End User 48
9.1 Introduction 48
9.2 Hospitals and Laboratories End Users, By Region 49
9.3 Academic and Research Centres end users market 50
9.4 Other end users market 51
10 Global liquid Biopsy Market, by Region 53
10.1 Introduction 53
10.2 North North America 54
10.2.1 US 59
10.2.2 CANADA 63
10.3 EUROPE 67
10.3.1 Germany 72
10.3.2 France 76
10.3.3 U.K. 80
10.3.4 Italy 84
10.3.5 Spain 88
10.3.6 Rest of Europe 92
10.4 APEC 97
10.4.1 Japan 103
10.4.2 China 107
10.4.3 India 111
10.4.4 Australia 115
10.4.5 Korea 119
10.4.6 Rest of Asia Pacific 123
10.5 Middle East and Africa 127
10.5.1 UAE 132
10.5.2 Saudi Arabia 136
10.5.3 Egypt 140
10.5.4 Rest of Middle East and Africa 144
11 Company Profile 149
11.1 Guardant Health, Inc 149
11.1.1 Company Overview 149
11.1.2 Product/Business Segment Overview 149
11.1.3 Financial Overview 149
11.1.4 Key Development 150
11.1.5 SWOT Analysis 151
11.2 Trovagene, Inc 152
11.2.1 Company Overview 152
11.2.2 Product/Business Segment Overview 152
11.2.3 Financial Overview 152
11.2.4 SWOT Analysis 153
11.3 RainDance Technologies, Inc. 155
11.3.1 Company Overview 155
11.3.2 Product/Business Segment Overview 155
11.3.3 Financial Overview 155
11.3.4 Key Development 155
11.3.5 SWOT Analysis 156
11.4 Agena Bioscience Inc. Inc. 157
11.4.1 Company Overview 157
11.4.2 Product/Business Segment Overview 157
11.4.3 Financial Overview 157
11.4.4 Key Development 157
11.5 Admera Health 159
11.5.1 Company Overview 159
11.5.2 Product/Business Segment Overview 159
11.5.3 Financial Overview 159
11.5.4 Key Development 159
11.5.5 SWOT Analysis 159
11.6 Biocept, Inc. 161
11.6.1 Company Overview 161
11.6.2 Product/Business Segment Overview 161
11.6.3 Financial Overview 161
11.6.4 Key Development 161
11.7 Circulogene Theranostics 162
11.7.1 Company Overview 162
11.7.2 Financial Overview 162
11.7.3 Key Development 162
11.8 Inivata Ltd 163
11.8.1 Company Overview 163
11.8.2 Product/Business Segment Overview 163
11.8.3 Financial Overview 163
11.8.4 Key Development 163
11.9 SAGA Diagnostics AB 164
11.9.1 Company Overview 164
11.9.2 Product/Business Segment Overview 164
11.9.3 Financial Overview 164
11.9.4 Key Development 164
11.10 Exosome Diagnostics 165
11.10.1 Company Overview 165
11.10.2 Financial Overview 165
11.10.3 Key Development 165
TABLE 1 global LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 34
TABLE 2 CIRCULATING TUMOR CELLS (CTCS) market, by region, 2014-2022 ($ million) 35
TABLE 3 Circulating Tumor DNA (CtDNA) market, by region, 2014-2022 ($ million) 39
TABLE 4 Medical devices market, by region, 2014-2022 ($ million) 40
TABLE 5 wearable devices market, by region, 2014-2022 ($ million) 44
TABLE 6 Connected Drug Delivery Systems market, by region, 2014-2022 ($ million) 48
TABLE 7 EXTRACELLULAR VESICLES (EVS) market, by region, 2014-2022 ($ million) 51
TABLE 8 Global LIQUID BIOPSY Value, by Application, 2014-2022 (USD million) 54
TABLE 9 Monitoring Applications Market, by region, 2014-2022 (USD million) 55
TABLE 10 Diagnosis & Treatments Market, by region, 2014-2022 (USD million) 56
TABLE 11 Education & Awareness Market, by region, 2014-2022 ($ million) 57
TABLE 12 Healthcare Managements Market, by region, 2014-2022 ($ million) 58
TABLE 13 Wellness & Preventions Market, by region, 2014-2022 (USD million) 59
TABLE 14 Other Applications: Global LIQUID BIOPSY Value, by Geography, 2014-2022 (USD million) 60
TABLE 15 Global liquid biopsy Market, by Region, 2014-2022($ Million) 63
TABLE 16 North America LIQUID BIOPSY, By Country, 2014-2022 ($ million) 64
TABLE 17 North America LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 65
TABLE 18 North America LIQUID BIOPSY, BY APPLICATION, 2014-2022 ($ MILLION) 66
TABLE 19 North America liquid biopsy market, by application, 2014-2022 ($ million) 66
TABLE 20 U.S. liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 67
TABLE 21 U.S. liquid biopsy Market, By Application, 2014-2022 ($ million) 68
TABLE 22 Canada LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 69
TABLE 23 Canada LIQUID BIOPSY, By application, 2014-2022 ($ million) 69
TABLE 24 Europe LIQUID BIOPSY, By Country, 2014-2022 ($ million) 71
TABLE 25 Europe liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 72
TABLE 26 Europe LIQUID BIOPSY, By application, 2014-2022 ($ million) 73
TABLE 27 Germany liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 73
TABLE 28 Germany liquid biopsy Market, By application, 2014-2022 ($ million) 74
TABLE 29 France liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 74
TABLE 30 France liquid biopsy Market, By application, 2014-2022 ($ million) 75
TABLE 31 U.K. LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 75
TABLE 32 U.K. LIQUID BIOPSY, By application, 2014-2022 ($ million) 76
TABLE 33 Italy liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 76
TABLE 34 Italy LIQUID BIOPSY, By application, 2014-2022 ($ million) 77
TABLE 35 Spain liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 77
TABLE 36 Spain LIQUID BIOPSY, By application, 2014-2022 ($ million) 78
TABLE 37 Asia-Pacific LIQUID BIOPSY, By Country, 2014-2022 ($ million) 80
TABLE 38 Asia-Pacific liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 81
TABLE 39 Asia-Pacific liquid biopsy Market, By application, 2014-2022 ($ million) 82
TABLE 40 Japan liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 83
TABLE 41 Japan liquid biopsy Market, By application, 2014-2022 ($ million) 83
TABLE 42 China liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 84
TABLE 43 China liquid biopsy Market, By application, 2014-2022 ($ million) 85
TABLE 44 India liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 86
TABLE 45 India liquid biopsy Market, By application, 2014-2022 ($ million) 86
TABLE 46 Australia liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 87
TABLE 47 Australia liquid biopsy Market, By application, 2014-2022 ($ million) 88
TABLE 48 Republic of Korea liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 88
TABLE 49 Republic of Korea liquid biopsy Market, By application, 2014-2022 ($ million) 89
TABLE 50 Middle East & Africa LIQUID BIOPSY, By Region, 2014-2022 ($ million) 90
TABLE 51 Middle East & Africa LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 91
TABLE 52 Middle East & Africa LIQUID BIOPSY, By Application, 2014-2022 ($ million) 92
TABLE 53 Connected healthcare: Partnerships, Agreements, and collaborations 94
TABLE 54 Connected healthcare: Product development and launch 98
TABLE 55 Connected healthcare: Approvals 99
TABLE 56 Connected healthcare: acquisitions 101
TABLE 57 CONNECTED HEALTHCARE: AWARD & RECOGNITION 101
TABLE 58 CONNECTED HEALTHCARE: Others 102
TABLE 59 Agamatrix, Inc.: Key Development 104
TABLE 60 AirStrip Technologies: Key Development 106
TABLE 61 AliveCor Inc.: Key Development 108
TABLE 62 ALLSCRIPTS: Key Development 112
TABLE 63 ATHENAHEALTH, INC.: Key Development 117
TABLE 64 BOSTON SCIENTIFIC CORPORATION: Key Development 119
TABLE 65 Cerner: Key Development 122
TABLE 66 GE HEALTHCARE: Key Development 126
TABLE 67 HONEYWELL LIFE CARE SOLUTIONS: Key Development 129
TABLE 68 Medtronics: Key Development 131
TABLE 69 Persistent Systems: Key Development 137
TABLE 70 Koninklijke Philips N.V.: Key Development 140
TABLE 71 Qualcomm: Key Development 143
TABLE 72 Sanofi: Key Development 146
FIGURE 1 Global Liquid Biopsy: Market Structure 17
FIGURE 2 Research Process of MRFR 18
FIGURE 3 Global LIQUID BIOPSY: Porter five forces analysis 27
FIGURE 4 Global liquid biopsy market, by BIOMARKER TYPE, Market share 2016 (%) 32
FIGURE 5 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, $ MILLION 2016 33
FIGURE 6 Circulating Tumor Cells (CTCs) market, by region, 2016, $ mILLION 34
FIGURE 7 Circulating tumor DNA (CtDNA) market, by region, 2016, $ million 35
FIGURE 8 Extracellular vesicles (EVS) market, by region, 2016 $ million 36
FIGURE 9 Other biomarker type market, by region, 2016, $ million 36
FIGURE 10 Global liquid biopsy market, by Therapeutic applications, Market share 2016 (%) 39
FIGURE 11 GLOBAL LIQUID BIOPSY MARKET BY Therapeutic applications, 2016, $ million 39
FIGURE 12 Cancer therapeutic application market, by region, 2014-2022 ($ million) 39
FIGURE 13 Cancer therapeutic application market, by region, 2016, $ million 40
FIGURE 14 Reproductive health therapeutic application market, by region, 2016, $ million 41
FIGURE 15 Other therapeutic application market, by region, 2016, $ million 41
FIGURE 16 Global liquid biopsy market, by Sample, Market share 2016 (%) 43
FIGURE 17 Global Liquid Biopsy Market by Sample, 2016, $ million 44
FIGURE 18 Blood Sample market, by region, 2016, $ million 45
FIGURE 19 Urine sample market, by region, 2016, $ million 45
FIGURE 20 Other sample market, by region, 2016, $ million 46
FIGURE 21 Global liquid biopsy market, by End User, Market share 2016 (%) 48
FIGURE 22 Global Liquid Biopsy Market by End User, 2016, $ million 49
FIGURE 23 Hospitals and Laboratories end users market by End User, 2016, $ million 49
FIGURE 24 Academic and Research Centers end users market, by End User, 2016, $ million 50
FIGURE 25 Other end users market, by End User, 2016, $ million 51
FIGURE 26 Global liquid biopsy market, by region, Market share 2016 (%) 53
FIGURE 27 Global liquid biopsy market, by region, 2014-2022 ($ million) 53
FIGURE 28 North AmericaNorth America liquid biopsy market, by COUNTRY, Market share 2016 (%) 54
FIGURE 29 North AmericaNorth America liquid biopsy market, by biomarker type, 2014-2022 ($ million) 55
FIGURE 30 North AmericaNorth America liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 56
FIGURE 31 North AmericaNorth America liquid biopsy market by sample type, 2014-2022 ($ million) 57
FIGURE 32 North AmericaNorth America liquid biopsy market by End users, 2014-2022 ($ million) 58
FIGURE 33 U.S. liquid biopsy market by biomarker type, 2014-2022 ($ million) 59
FIGURE 34 U.S. liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 60
FIGURE 35 U.S. liquid biopsy market by sample type, 2014-2022 ($ million) 61
FIGURE 36 U.S. liquid biopsy market by End users, 2014-2022 ($ million) 62
FIGURE 37 Canada liquid biopsy market by biomarker type, 2014-2022 ($ million) 63
FIGURE 38 Canada liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 64
FIGURE 39 Canada liquid biopsy market by sample type, 2014-2022 ($ million) 65
FIGURE 40 Canada liquid biopsy market by End users 66
FIGURE 41 Europe liquid biopsy market By Country, Market share 2016 (%) 67
FIGURE 42 Europe liquid biopsy market By Country, 2014-2022 ($ million) 68
FIGURE 43 Europe liquid biopsy market by biomarker type, 2014-2022 ($ million) 69
FIGURE 44 Europe liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 70
FIGURE 45 Europe liquid biopsy market by sample type, 2014-2022 ($ million) 71
FIGURE 46 Europe liquid biopsy market by End users, 2014-2022 ($ million) 72
FIGURE 47 Germany liquid biopsy market by biomarker type, 2014-2022 ($ million) 73
FIGURE 48 Germany liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 74
FIGURE 49 Germany liquid biopsy market by sample type, 2014-2022 ($ million) 75
FIGURE 50 Germany liquid biopsy market by End users, 2014-2022 ($ million) 75
FIGURE 51 France liquid biopsy market by biomarker type, 2014-2022 ($ million) 76
FIGURE 52 France liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 77
FIGURE 53 France liquid biopsy market by sample type, 2014-2022 ($ million) 78
FIGURE 54 France liquid biopsy market by End users, 2014-2022 ($ million) 79
FIGURE 55 U.K. liquid biopsy market by biomarker type, 2014-2022 ($ million) 80
FIGURE 56 U.K. liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 81
FIGURE 57 U.K. liquid biopsy market by sample type, 2014-2022 ($ million) 82
FIGURE 58 U.K. liquid biopsy market by End users, 2014-2022 ($ million) 83
FIGURE 59 Italy liquid biopsy market by biomarker type, 2014-2022 ($ million) 84
FIGURE 60 Italy liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 85
FIGURE 61 Italy liquid biopsy market by sample type, 2014-2022 ($ million) 86
FIGURE 62 Italy liquid biopsy market by End users, 2014-2022 ($ million) 87
FIGURE 63 Spain liquid biopsy market by biomarker type, 2014-2022 ($ million) 88
FIGURE 64 Spain liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 89
FIGURE 65 Spain liquid biopsy market by sample type, 2014-2022 ($ million) 90
FIGURE 66 Spain liquid biopsy market by End users, 2014-2022 ($ million) 91
FIGURE 67 Rest of Europe liquid biopsy market by biomarker type, 2014-2022 ($ million) 92
FIGURE 68 Rest of Europe liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 93
FIGURE 69 Rest of Europe liquid biopsy market by sample type, 2014-2022 ($ million) 94
FIGURE 70 Rest of Europe liquid biopsy market by End users, 2014-2022 ($ million) 95
FIGURE 71 APEC liquid biopsy market By Country, Market share 2016 (%) 97
FIGURE 72 APEC liquid biopsy market by country, 2014-2022 ($ million) 99
FIGURE 73 APEC liquid biopsy market by biomarker type, 2014-2022 ($ million) 100
FIGURE 74 Asia Pacific liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 101
FIGURE 75 Asia Pacific liquid biopsy market by sample type, 2014-2022 ($ million) 102
FIGURE 76 Asia Pacific liquid biopsy market by End users, 2014-2022 ($ million) 103
FIGURE 77 Japan liquid biopsy market by biomarker type, 2014-2022 ($ million) 104
FIGURE 78 Japan liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 104
FIGURE 79 Japan liquid biopsy market by sample type, 2014-2022 ($ million) 105
FIGURE 80 Japan liquid biopsy market by End users, 2014-2022 ($ million) 106
FIGURE 81 China liquid biopsy market by biomarker type, 2014-2022 ($ million) 107
FIGURE 82 China liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 108
FIGURE 83 China liquid biopsy market by sample type, 2014-2022 ($ million) 109
FIGURE 84 China liquid biopsy market by End users, 2014-2022 ($ million) 110
FIGURE 85 India liquid biopsy market by biomarker type, 2014-2022 ($ million) 111
FIGURE 86 India liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 112
FIGURE 87 India liquid biopsy market by sample type, 2014-2022 ($ million) 113
FIGURE 88 India liquid biopsy market by End users, 2014-2022 ($ million) 114
FIGURE 89 Australia liquid biopsy market by biomarker type, 2014-2022 ($ million) 115
FIGURE 90 Australia liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 116
FIGURE 91 Australia liquid biopsy market by sample type, 2014-2022 ($ million) 117
FIGURE 92 Australia liquid biopsy market by sample type, 2014-2022 ($ million) 117
FIGURE 93 Australia liquid biopsy market by End users, 2014-2022 ($ million) 118
FIGURE 94 Republic of Korea liquid biopsy market by biomarker type, 2014-2022 ($ million) 119
FIGURE 95 Republic of Korea liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 120
FIGURE 96 Republic of Korea liquid biopsy market by sample type, 2014-2022 ($ million) 121
FIGURE 97 Republic of Korea liquid biopsy market by End users, 2014-2022 ($ million) 122
FIGURE 98 Rest of Asia Pacific liquid biopsy market by biomarker type, 2014-2022 ($ million) 123
FIGURE 99 Rest of Asia Pacific liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 124
FIGURE 100 Rest of Asia Pacific liquid biopsy market by sample type, 2014-2022 ($ million) 125
FIGURE 101 Rest of Asia Pacific liquid biopsy market by End users, 2014-2022 ($ million) 126
FIGURE 102 Middle East and Africa liquid biopsy market, Market share By Country, 2016 (%) 127
FIGURE 103 Middle East and Africa liquid biopsy market By Country, 2014-2022 ($ million) 128
FIGURE 104 Middle East and Africa liquid biopsy market by biomarker type, 2014-2022 ($ million) 129
FIGURE 105 Middle East and Africa liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 130
FIGURE 106 Middle East and Africa liquid biopsy market by sample type, 2014-2022 ($ million) 131
FIGURE 107 Middle East and Africa liquid biopsy market by End users, 2014-2022 ($ million) 132
FIGURE 108 UAE liquid biopsy market by biomarker type, 2014-2022 ($ million) 132
FIGURE 109 UAE liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 133
FIGURE 110 UAE liquid biopsy market by sample type, 2014-2022 ($ million) 134
FIGURE 111 UAE liquid biopsy market by End users, 2014-2022 ($ million) 135
FIGURE 112 Saudi Arabia liquid biopsy market by biomarker type, 2014-2022 ($ million) 137
FIGURE 113 Saudi Arabia liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 137
FIGURE 114 Saudi Arabia liquid biopsy market by sample type, 2014-2022 ($ million) 138
FIGURE 115 Saudi Arabia liquid biopsy market by End users, 2014-2022 ($ million) 139
FIGURE 116 Egypt liquid biopsy market by biomarker type, 2014-2022 ($ million) 140
FIGURE 117 Egypt liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 141
FIGURE 118 Egypt liquid biopsy market by sample type, 2014-2022 ($ million) 142
FIGURE 119 Egypt liquid biopsy market by End users, 2014-2022 ($ million) 143
FIGURE 120 Rest of Middle East and Africa liquid biopsy market by biomarker type, 2014-2022 ($ million) 144
FIGURE 121 Rest of Middle East and Africa liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 145
FIGURE 122 Rest of Middle East and Africa liquid biopsy market by sample type, 2014-2022 ($ million) 146
FIGURE 123 Rest of Middle East and Africa liquid biopsy market by End users, 2014-2022 ($ million) 147
FIGURE 124 Guardant Health, Inc: SWOT ANALYSIS 151
FIGURE 126 Trovagene, Inc Corporation: SWOT ANALYSIS 155
FIGURE 1 RAINDANCE: RECENT FINANCIAL 157
FIGURE 2 RainDance Technologies: SWOT ANALYSIS 158
FIGURE 3 Admera Health: SWOT ANALYSIS 159
FIGURE 4 BIOCEPT, INC.: SWOT ANALYSIS 161
FIGURE 5 CIRCULOGENE THERANOSTICS: SWOT ANALYSIS 163
FIGURE 6 SAGA DIAGNOSTICS AB: SWOT ANALYSIS 165
FIGURE 7 AGENA BIOSCIENCE INC.: SWOT ANALYSIS 167
FIGURE 8 Exosome Diagnostics: SWOT ANALYSIS 170
